Head-to-head dispatch
Breeze Meds vs Signos
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Charges nothing until a provider approves you — but keeps its pricing inside the intake.
Marked down on: The public site names no molecule behind its "from $199" — tirzepatide pricing only appears inside the intake
Desk Score
Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app — pairing the medication with…
Marked down on: Compounded GLP-1s are not FDA-approved finished products
Breeze Meds takes this head-to-head with the higher Desk Score, 79/100 (C+) against 62/100 (C) for Signos. Signos still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Breeze Meds
79/100
C+
Signos
62/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Breeze Meds | Signos |
|---|---|---|
| Semaglutide | From $199/mo | $199/mo (6-month plan, compounded) |
| Tirzepatide | From $299/mo first month, $399/mo thereafter | $199/mo (starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | People who want an all-in nationwide option and do not mind an intake to learn the price. | Readers who want pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app. |
| Desk Score | 79/100C+ | 62/100C |
The verdict
Desk pick — Breeze MedsBreeze Meds takes this head-to-head with the higher Desk Score, 79/100 (C+) against 62/100 (C) for Signos. Signos still holds its ground where its strengths line up with yours.
Choose Breeze Meds if…
People who want an all-in nationwide option and do not mind an intake to learn the price.
From $199/mo sema · From $299/mo first month, $399/mo thereafter tirz · All 50 states
Choose Signos if…
Readers who want pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app.
$199/mo (6-month plan, compounded) sema · $199/mo (starting dose, compounded) tirz · Coverage not published
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Breeze Meds · Signos.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Breeze Meds vs CoreAge Rx
- Signos vs Vaylen
- Breeze Meds vs Strut Health
- Signos vs Ondra Health
- Breeze Meds vs Invigor Medical
- Signos vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.